3 results
Primary:* * To determine the antitumor activity of single-agent enfortumab vedotin as measured by confirmed objective response rate (ORR) in patients with locally advanced or metastatic urothelial cancer who have previously received systemic therapy…
The aim of the study is, to analyze the effect of the haemoadsorption device Cytosorb in relation to the inflammatory parameters IL-6, IL-8, IL-10,TNF-* and CRP at six different time points during conventional CABG procedures.We assess whether the…
Study Objective(s):Primary-To compare the overall survival (OS) of subjects with locally advanced or metastatic urothelialcancer treated with enfortumab vedotin (EV) to the OS of subjects treated with chemotherapySecondary-To compare progression-…